Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Clinical trial NCT02515175 · COMPLETED

Trial details

NCT number: NCT02515175
Sponsor: Genocea Biosciences, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Genital Herpes Simplex Type 2

Start date: 2015-11-01
Primary completion: 2016-07-01
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.